{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T04:19:18Z","timestamp":1729829958795,"version":"3.28.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,24]]},"DOI":"10.7759\/cureus.72283","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T13:05:07Z","timestamp":1729775107000},"source":"Crossref","is-referenced-by-count":0,"title":["An Evaluation of the Safety of Half-Dose Direct Oral Anticoagulants Following Total Joint Arthroplasty: A Pilot Study"],"prefix":"10.7759","author":[{"given":"Harrison A","family":"Patrizio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rex  W","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie A","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Lencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory K","family":"Deirmengian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2016.11.055","article-title":"Complications following outpatient total joint arthroplasty: an analysis of a national database","volume":"32","author":"Courtney PM","year":"2017","unstructured":"Courtney PM, Boniello AJ, Berger RA. Complications following outpatient total joint arthroplasty: an analysis of a national database. J Arthroplasty. 2017, 32:1426-30. 10.1016\/j.arth.2016.11.055","journal-title":"J Arthroplasty"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3928\/01477447-20140124-23","article-title":"Seasonality of infection rates after total joint arthroplasty","volume":"37","author":"Kane P","year":"2014","unstructured":"Kane P, Chen C, Post Z, Radcliff K, Orozco F, Ong A. Seasonality of infection rates after total joint arthroplasty. Orthopedics. 2014, 37:e182-6. 10.3928\/01477447-20140124-23","journal-title":"Orthopedics"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8111891","article-title":"Complications in total joint arthroplasties","volume":"8","author":"G\u00f3mez-Barrena E","year":"2019","unstructured":"G\u00f3mez-Barrena E, Garc\u00eda-Rey E. Complications in total joint arthroplasties. J Clin Med. 2019, 8:1891. 10.3390\/jcm8111891","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.775126","article-title":"New oral anticoagulants for venous thromboembolism prophylaxis in total hip and knee arthroplasty: a systematic review and network meta-analysis","volume":"12","author":"Yi YH","year":"2021","unstructured":"Yi YH, Gong S, Gong TL, Zhou LY, Hu C, Xu WH. New oral anticoagulants for venous thromboembolism prophylaxis in total hip and knee arthroplasty: a systematic review and network meta-analysis. Front Pharmacol. 2021, 12:775126. 10.3389\/fphar.2021.775126","journal-title":"Front Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger CB","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, et al.. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011, 365:981-92. 10.1056\/NEJMoa1107039","journal-title":"N Engl J Med"},{"key":"ref6","article-title":"","author":"Singh R","year":"2023","unstructured":"Singh R, Emmady PD. Rivaroxaban. StatPearls Publishing, Treasure Island, FL; 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557502\/."},{"key":"ref7","article-title":"","author":"Agrawal A","year":"2023","unstructured":"Agrawal A, Kerndt CC, Manna B. Apixaban. StatPearls Publishing, Treasure Island, FL; 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507910\/."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1160\/TH17-08-0553","article-title":"The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) study for patients on a direct oral anticoagulant who need an elective surgery or procedure: design and rationale","volume":"117","author":"Douketis JD","year":"2017","unstructured":"Douketis JD, Spyropoulos AC, Anderson JM, et al.. The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) study for patients on a direct oral anticoagulant who need an elective surgery or procedure: design and rationale. Thromb Haemost. 2017, 117:2415-24. 10.1160\/TH17-08-0553","journal-title":"Thromb Haemost"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.123.065614","article-title":"Associations of apixaban dose with safety and effectiveness outcomes in patients with atrial fibrillation and severe chronic kidney disease","volume":"148","author":"Xu Y","year":"2023","unstructured":"Xu Y, Chang AR, Inker LA, McAdams-DeMarco M, Grams ME, Shin JI. Associations of apixaban dose with safety and effectiveness outcomes in patients with atrial fibrillation and severe chronic kidney disease. Circulation. 2023, 148:1445-54. 10.1161\/CIRCULATIONAHA.123.065614","journal-title":"Circulation"},{"key":"ref10","unstructured":"Updates to the ASRA Guidelines for Interventional Pain Procedures. ASRA Pain Medicine. (2024). Accessed. September 21, 2024: https:\/\/www.asra.com\/news-publications\/asra-newsletter\/newsletter-item\/asra-news\/2019\/08\/27\/updates-to-the-asra-guide...."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2023.02.028","article-title":"Safety and efficacy of rivaroxaban in primary total hip and knee arthroplasty","volume":"38","author":"Piple AS","year":"2023","unstructured":"Piple AS, Wang JC, Kang HP, et al.. Safety and efficacy of rivaroxaban in primary total hip and knee arthroplasty. J Arthroplasty. 2023, 38:1613-20.e4. 10.1016\/j.arth.2023.02.028","journal-title":"J Arthroplasty"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2019.03.057","article-title":"Changing patterns of anticoagulation after total hip arthroplasty in the United States: frequency of deep vein thrombosis, pulmonary embolism, and complications with rivaroxaban and\u00a0warfarin","volume":"34","author":"Glassberg MB","year":"2019","unstructured":"Glassberg MB, Lachiewicz PF. Changing patterns of anticoagulation after total hip arthroplasty in the United States: frequency of deep vein thrombosis, pulmonary embolism, and complications with rivaroxaban and\u00a0warfarin. J Arthroplasty. 2019, 34:1793-801. 10.1016\/j.arth.2019.03.057","journal-title":"J Arthroplasty"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.L.01031","article-title":"A mobile compression device for thrombosis prevention in hip and knee arthroplasty","volume":"96","author":"Colwell CW Jr","year":"2014","unstructured":"Colwell CW Jr, Froimson MI, Anseth SD, et al.. A mobile compression device for thrombosis prevention in hip and knee arthroplasty. J Bone Joint Surg Am. 2014, 96:177-83. 10.2106\/JBJS.L.01031","journal-title":"J Bone Joint Surg Am"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2013.05.025","article-title":"DVT prophylaxis after TKA: routine anticoagulation vs risk screening approach - a randomized study","volume":"28","author":"Kulshrestha V","year":"2013","unstructured":"Kulshrestha V, Kumar S. DVT prophylaxis after TKA: routine anticoagulation vs risk screening approach - a randomized study. J Arthroplasty. 2013, 28:1868-73. 10.1016\/j.arth.2013.05.025","journal-title":"J Arthroplasty"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/os.12542","article-title":"Comparison of the efficacy and safety of aspirin and rivaroxaban following enoxaparin treatment for prevention of venous thromboembolism after hip fracture surgery","volume":"11","author":"Huang Q","year":"2019","unstructured":"Huang Q, Xing SX, Zeng Y, Si HB, Zhou ZK, Shen B. Comparison of the efficacy and safety of aspirin and rivaroxaban following enoxaparin treatment for prevention of venous thromboembolism after hip fracture surgery. Orthop Surg. 2019, 11:886-94. 10.1111\/os.12542","journal-title":"Orthop Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa076016","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty","volume":"358","author":"Lassen MR","year":"2008","unstructured":"Lassen MR, Ageno W, Borris LC, et al.. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med. 2008, 358:2776-86. 10.1056\/NEJMoa076016","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S54714","article-title":"Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty","volume":"10","author":"Levitan B","year":"2014","unstructured":"Levitan B, Yuan Z, Turpie AG, et al.. Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty. Vasc Health Risk Manag. 2014, 10:157-67. 10.2147\/VHRM.S54714","journal-title":"Vasc Health Risk Manag"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2023.04.044","article-title":"The fate of the patient with superficial dehiscence following direct anterior total hip arthroplasty","volume":"38","author":"Wilson JM","year":"2023","unstructured":"Wilson JM, Hadley ML, Ledford CK, Bingham JS, Taunton MJ. The fate of the patient with superficial dehiscence following direct anterior total hip arthroplasty. J Arthroplasty. 2023, 38:S420-5. 10.1016\/j.arth.2023.04.044","journal-title":"J Arthroplasty"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2015.03.043","article-title":"Complications following direct anterior hip procedures: costs to both patients and surgeons","volume":"30","author":"Lee GC","year":"2015","unstructured":"Lee GC, Marconi D. Complications following direct anterior hip procedures: costs to both patients and surgeons. J Arthroplasty. 2015, 30:98-101. 10.1016\/j.arth.2015.03.043","journal-title":"J Arthroplasty"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-010-1568-1","article-title":"High complication rate with anterior total hip arthroplasties on a fracture table","volume":"469","author":"Jewett BA","year":"2011","unstructured":"Jewett BA, Collis DK. High complication rate with anterior total hip arthroplasties on a fracture table. Clin Orthop Relat Res. 2011, 469:503-7. 10.1007\/s11999-010-1568-1","journal-title":"Clin Orthop Relat Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.0785","article-title":"Association between surgical approach and major surgical complications in patients undergoing total hip arthroplasty","volume":"323","author":"Pincus D","year":"2020","unstructured":"Pincus D, Jenkinson R, Paterson M, Leroux T, Ravi B. Association between surgical approach and major surgical complications in patients undergoing total hip arthroplasty. JAMA. 2020, 323:1070-6. 10.1001\/jama.2020.0785","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2018.03.012","article-title":"How fast should a total knee arthroplasty be performed? An analysis of 140,199 surgeries","volume":"33","author":"George J","year":"2018","unstructured":"George J, Mahmood B, Sultan AA, Sodhi N, Mont MA, Higuera CA, Stearns KL. How fast should a total knee arthroplasty be performed? An analysis of 140,199 surgeries. J Arthroplasty. 2018, 33:2616-22. 10.1016\/j.arth.2018.03.012","journal-title":"J Arthroplasty"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/1754-9493-5-26","article-title":"Modality of wound closure after total knee replacement: are staples as safe as sutures? A retrospective study of 181 patients","volume":"5","author":"Newman JT","year":"2011","unstructured":"Newman JT, Morgan SJ, Resende GV, Williams AE, Hammerberg EM, Dayton MR. Modality of wound closure after total knee replacement: are staples as safe as sutures? A retrospective study of 181 patients. Patient Saf Surg. 2011, 5:26. 10.1186\/1754-9493-5-26","journal-title":"Patient Saf Surg"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2017.04.004","article-title":"A meta-analysis and systematic review evaluating skin closure after total knee arthroplasty-what is the best method?","volume":"32","author":"Kim KY","year":"2017","unstructured":"Kim KY, Anoushiravani AA, Long WJ, Vigdorchik JM, Fernandez-Madrid I, Schwarzkopf R. A meta-analysis and systematic review evaluating skin closure after total knee arthroplasty-what is the best method?. J Arthroplasty. 2017, 32:2920-7. 10.1016\/j.arth.2017.04.004","journal-title":"J Arthroplasty"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2019.2431","article-title":"Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant","volume":"179","author":"Douketis JD","year":"2019","unstructured":"Douketis JD, Spyropoulos AC, Duncan J, et al.. Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant. JAMA Intern Med. 2019, 179:1469-78. 10.1001\/jamainternmed.2019.2431","journal-title":"JAMA Intern Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative bridging anticoagulation in patients with atrial fibrillation","volume":"373","author":"Douketis JD","year":"2015","unstructured":"Douketis JD, Spyropoulos AC, Kaatz S, et al.. Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med. 2015, 373:823-33. 10.1056\/NEJMoa1501035","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000000366","article-title":"Comparison of low-dose (162\u00a0mg) and high-dose (650\u00a0mg) Aspirin prophylaxis following total joint arthroplasty: a prospective cohort study","volume":"85","author":"Shafiei SH","year":"2023","unstructured":"Shafiei SH, Rastegar M, Mirghaderi P, Siavashi B, Mortazavi SM. Comparison of low-dose (162\u00a0mg) and high-dose (650\u00a0mg) Aspirin prophylaxis following total joint arthroplasty: a prospective cohort study. Ann Med Surg (Lond). 2023, 85:1461-7. 10.1097\/MS9.0000000000000366","journal-title":"Ann Med Surg (Lond)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1712746","article-title":"Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty","volume":"378","author":"Anderson DR","year":"2018","unstructured":"Anderson DR, Dunbar M, Murnaghan J, et al.. Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty. N Engl J Med. 2018, 378:699-707. 10.1056\/NEJMoa1712746","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/309608-an-evaluation-of-the-safety-of-half-dose-direct-oral-anticoagulants-following-total-joint-arthroplasty-a-pilot-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T13:05:09Z","timestamp":1729775109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/309608-an-evaluation-of-the-safety-of-half-dose-direct-oral-anticoagulants-following-total-joint-arthroplasty-a-pilot-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.72283","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,24]]}}}